Back to Journals » International Journal of Nanomedicine » Volume 8 » Issue 1

Development and characterization of an injectable cement of nano calcium-deficient hydroxyapatite/multi(amino acid) copolymer/calcium sulfate hemihydrate for bone repair

Authors Qi X, Li H, Qiao B , Li W, Hao X, Wu J, Su B, Jiang D

Received 10 September 2013

Accepted for publication 9 October 2013

Published 21 November 2013 Volume 2013:8(1) Pages 4441—4452

DOI https://doi.org/10.2147/IJN.S54289

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 4



Xiaotong Qi,1 Hong Li,2 Bo Qiao,1 Weichao Li,1 Xinyan Hao,2 Jun Wu,1 Bao Su,1 Dianming Jiang1

1Department of Orthopedics, The First Affiliated Hospital, Chongqing Medical University, Chongqing, People's Republic of China; 2School of Physical Science and Technology, Sichuan University, Chengdu, People's Republic of China

Abstract: A novel injectable bone cement was developed by integration of nano calcium-deficient hydroxyapatite/multi(amino acid) copolymer (n-CDHA/MAC) and calcium sulfate hemihydrate (CSH; CaSO4 · 1/2H2O). The structure, setting time, and compressive strength of the cement were investigated. The results showed that the cement with a liquid to powder ratio of 0.8 mL/g exhibited good injectability and appropriate setting time and mechanical properties. In vitro cell studies indicated that MC3T3-E1 cells cultured on the n-CDHA/MAC/CSH composite spread well and showed a good proliferation state. The alkaline phosphatase activity of the MC3T3-E1 cells cultured on the n-CDHA/MAC/CSH composite was significantly higher than that of the cells on pure CSH at 4 and 7 days of culture. The n-CDHA/MAC/CSH cement was implanted into critical size defects of the femoral condyle in rabbits to evaluate its biocompatibility and osteogenesis in vivo. Radiological and histological results indicated that introduction of the n-CDHA/MAC into CSH enhanced new bone formation, and the n-CDHA/MAC/CSH cement exhibited good biocompatibility and degradability. In conclusion, the injectable n-CDHA/MAC/CSH composite cement has a significant clinical advantage over pure CSH cement, and may be a promising bone graft substitute for the treatment of bone defects.

Keywords:
calcium-deficient hydroxyapatite, multi(amino acid) copolymer, calcium sulfate hemihydrate, injectability, biocompatibility, osteogenesis

Creative Commons License © 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.